Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.475, 2005-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The pros and cons of Rx-to-OTC switching of drugs in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. :
Access to resources
Recommend
The pros and cons of Rx-to-OTC switching of drugs in the US
Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. :
Third party Rx-to-OTC switching in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 362, 2002-01 ,pp. :
Loratadine OTC switch approved, cost saving in the US
Inpharma, Vol. 1, Iss. 1367, 2002-01 ,pp. :
Rich choose Rx over OTC drugs after charges scrapped in Wales
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 549, 2008-01 ,pp. :